Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study.
Sign Up to like & getrecommendations! Published in 2021 at "Primary care diabetes"
DOI: 10.1016/j.pcd.2021.06.008
Abstract: AIMS As part of the SURE programme, SURE Denmark/Sweden aimed to study the real-world use of once-weekly (OW) semaglutide in adults with type 2 diabetes (T2D) in Denmark/Sweden. METHODS SURE Denmark/Sweden was an ∼30-week, prospective,… read more here.
Keywords: real world; use; study; sure denmark ... See more keywords